Logo-ps

Submitted: 23 Feb 2026
Revision: 22 Jul 2026
Accepted: 28 Jul 2026
ePublished: 03 Oct 2026
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Pharm Sci. Inpress.
  Abstract View: 24

Original Article

Isorhamnetin Protects against Isoproterenol-Induced Myocardial Infarction via Modulation of Oxidative Stress, Apoptosis, and Membrane-Bound ATPase Activities in Rats

Ramaraj Dheshika ORCID logo, Ragunathan Subashini* ORCID logo
*Corresponding Author: Email: dr.r.subashini@gamil.com

Abstract

Background: Myocardial infarction (MI) is a leading cause of death worldwide, primarily associated with oxidative stress, inflammation, apoptosis, and ionic imbalance. Isoproterenol (ISO)-induced MI in rats mimics human cardiac injury. Flavonoids have gained attention for their antioxidant and cardioprotective effects. Isorhamnetin, a natural flavonoid, possesses potent antioxidant and anti-inflammatory properties, but its cardioprotective mechanisms in MI remain unclear. This study aimed to evaluate the protective role of isorhamnetin against ISO-induced MI in rats. Methods: Male Wistar albino rats were divided into four groups: normal control, isorhamnetin alone (10 mg/kg), ISO-induced MI (100 mg/kg, s.c., 2 days), and ISO + isorhamnetin-treated. Cardiac injury biomarkers (CK-MB, cTn-T, cTn-I), lipid peroxidation, antioxidant status (enzymatic and non-enzymatic), membrane-bound ATPase activities, and electrolyte levels were assessed. Apoptosis-related proteins were measured by ELISA and gene expression by RT-PCR. Histopathology was performed using H&E and Masson’s trichrome staining. In vitro antioxidant activity was assessed via DPPH and ABTS+ assays. Results: ISO administration significantly increased cardiac biomarkers, lipid peroxidation, apoptotic markers, electrolyte imbalance, and histological damage, while reducing antioxidant defenses and Na⁺/K⁺-ATPase activity (P<0.05). Isorhamnetin treatment mitigated these changes by restoring antioxidant enzymes, reducing oxidative stress, normalizing ATPase function and ionic balance, and inhibiting Fas-receptor and caspase-mediated apoptosis (P<0.05). Histology revealed reduced necrosis, inflammation, edema, and fibrosis. In vitro assays confirmed strong free radical scavenging activity of isorhamnetin. Conclusion: Isorhamnetin protects against ISO-induced MI by reducing oxidative stress, preserving membrane integrity, maintaining ionic homeostasis, and suppressing apoptosis. These findings highlight isorhamnetin as a promising natural cardioprotective agent for MI.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 24

Your browser does not support the canvas element.

PDF Download: 0

Your browser does not support the canvas element.